Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ishares Genomics Immunology and Healthcare ETF (IDNA)

Ishares Genomics Immunology and Healthcare ETF (IDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 24,318,000
  • Market Capitalization, $K 24,318
  • Shares Outstanding, K 900
  • 60-Month Beta 1.59
  • Price/Earnings ttm 17.08
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.47%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.96 +11.46%
on 10/21/19
27.82 unch
on 11/20/19
+3.17 (+12.85%)
since 10/18/19
3-Month
23.62 +17.78%
on 10/03/19
27.82 unch
on 11/20/19
+1.11 (+4.14%)
since 08/20/19

Most Recent Stories

More News
Value Biotech ETFs & Stocks to Buy Now

Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.

ABBV : 87.79 (-1.38%)
BMY : 55.90 (-1.03%)
MRK : 84.81 (+0.19%)
RHHBY : 38.1100 (-0.50%)
LLY : 115.36 (+0.23%)
GSK : 44.00 (-1.12%)
XBI : 87.86 (+0.75%)
BBH : 136.33 (+0.60%)
AMGN : 225.86 (+0.61%)
BIIB : 287.85 (+0.85%)
CELG : 108.09 (-0.04%)
IDNA : 27.89 (+0.90%)
ETFs Poised to Benefit from Gene Editing Revolution

Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.

AGN : 184.65 (-0.31%)
PBE : 53.13 (+0.40%)
ONCE : 111.70 (+0.33%)
EDIT : 24.67 (-1.16%)
ARKG : 33.19 (+1.10%)
GNOM : 14.47 (+0.03%)
IDNA : 27.89 (+0.90%)
ETFs to Gain From the Booming Genomics Market

Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.

PBE : 53.13 (+0.40%)
ILMN : 315.14 (+1.33%)
IDNA : 27.89 (+0.90%)
GNOM : 14.47 (+0.03%)
ARKG : 33.19 (+1.10%)
Trade IDNA with:

Fund Summary

The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 27.75
1st Resistance Point 27.70
Last Price 27.89
1st Support Level 27.54
2nd Support Level 27.44

See More

52-Week High 27.96
Last Price 27.89
Fibonacci 61.8% 26.30
Fibonacci 50% 25.79
Fibonacci 38.2% 25.28
52-Week Low 23.62

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar